These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7348213)

  • 1. Cardiovascular protection by Ca antagonists.
    Fleckenstein A; Fleckenstein-Grün G
    Eur Heart J; 1980 Dec; 1(Suppl B):15-21. PubMed ID: 7348213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM; Ayad MJ; Robertson RM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 8. Selectivity of calcium antagonistic action in vascular smooth muscle.
    van Breemen C; Mangel A; Fahim M; Meisheri K
    Am J Cardiol; 1982 Feb; 49(3):507-10. PubMed ID: 6277176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticholinesterase effect of calcium channel blockers: diltiazem, verapamil, and nifedipine].
    Ivanov IuIa
    Dokl Akad Nauk; 1998 Mar; 359(3):413-4. PubMed ID: 9608914
    [No Abstract]   [Full Text] [Related]  

  • 13. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MCI-176, a new calcium antagonist, on the calcium induced contraction of isolated porcine coronary arteries.
    Ishibashi A; Horii D
    Jpn J Pharmacol; 1987 Feb; 43(2):234-6. PubMed ID: 3573428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists.
    Nayler WG
    Eur Heart J; 1980 Jun; 1(3):225-37. PubMed ID: 7285980
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.
    Skärby TV; Högestätt ED
    Br J Pharmacol; 1990 Dec; 101(4):961-7. PubMed ID: 1707708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis, calcium, and calcium antagonists.
    Henry PD
    Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic uses of calcium channel blockers.
    Zaret GM
    Am Fam Physician; 1983 Apr; 27(4):210-21. PubMed ID: 6837404
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.